Followers | 472 |
Posts | 30151 |
Boards Moderated | 1 |
Alias Born | 11/12/2016 |
Saturday, March 02, 2024 9:50:16 PM
I expect OTC approval in 2025 (if at all) because they have a trial that ends Dec 2024 which they will present to FDA
So its a long hold with a possible spike in March on FDA meetings
Recent PTPI News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/25/2024 09:02:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/25/2024 09:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2024 09:00:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 09:07:39 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/15/2024 09:19:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 09:15:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 08:05:18 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/31/2024 09:07:28 PM
- Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:32:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:05:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:05:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:07:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:06:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:05:30 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/30/2023 09:05:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 10:11:15 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 10:00:18 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM